These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18510171)

  • 41. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
    Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
    Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
    [TBL] [Abstract][Full Text] [Related]  

  • 42. p53 may mediate the mdr-1 expression via the WT1 gene in human vincristine-resistant leukemia/lymphoma cell lines.
    Hirose M; Kuroda Y
    Cancer Lett; 1998 Jul; 129(2):165-71. PubMed ID: 9719458
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gene expression profiles classify human osteosarcoma xenografts according to sensitivity to doxorubicin, cisplatin, and ifosfamide.
    Bruheim S; Xi Y; Ju J; Fodstad O
    Clin Cancer Res; 2009 Dec; 15(23):7161-9. PubMed ID: 19920113
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monitoring the gene expression profiles of doxorubicin-resistant acute myelocytic leukemia cells by DNA microarray analysis.
    Song JH; Choi CH; Yeom HJ; Hwang SY; Kim TS
    Life Sci; 2006 Jun; 79(2):193-202. PubMed ID: 16458935
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantification of the expression of multidrug resistance-related genes in human tumour cell lines grown with free doxorubicin or doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres.
    Laurand A; Laroche-Clary A; Larrue A; Huet S; Soma E; Bonnet J; Robert J
    Anticancer Res; 2004; 24(6):3781-8. PubMed ID: 15736412
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sequential gene expression of P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and lung resistance protein: functional activity of P-gp and MRP present in the doxorubicin-resistant human K562 cell lines.
    Grandjean F; Brémaud L; Verdier M; Robert J; Ratinaud MH
    Anticancer Drugs; 2001 Mar; 12(3):247-58. PubMed ID: 11290872
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Establishment of new multidrug-resistant human osteosarcoma cell lines.
    Oda Y; Matsumoto Y; Harimaya K; Iwamoto Y; Tsuneyoshi M
    Oncol Rep; 2000; 7(4):859-66. PubMed ID: 10854558
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytotoxic effect of doxorubicin on human multiple myeloma cells in vitro.
    Shushanov SS; Kravtsova TA
    Bull Exp Biol Med; 2013 Jun; 155(2):228-32. PubMed ID: 24130997
    [TBL] [Abstract][Full Text] [Related]  

  • 49. cDNA microarray analysis of multidrug resistance: doxorubicin selection produces multiple defects in apoptosis signaling pathways.
    Watts GS; Futscher BW; Isett R; Gleason-Guzman M; Kunkel MW; Salmon SE
    J Pharmacol Exp Ther; 2001 Nov; 299(2):434-41. PubMed ID: 11602652
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acquisition of doxorubicin resistance in human leukemia HL-60 cells is reproducibly associated with 7q21 chromosomal anomalies.
    Ganapathi R; Hoeltge G; Casey G; Grabowski D; Neelon R; Ford J
    Cancer Genet Cytogenet; 1996 Feb; 86(2):116-9. PubMed ID: 8603335
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of Pgp activity and cell cycle-dependent chemosensitivity to doxorubicin in the multidrug-resistant LoVo human colon cancer cell line.
    Toffoli G; Corona G; Gigante M; Boiocchi M
    Eur J Cancer; 1996 Aug; 32A(9):1591-7. PubMed ID: 8911123
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.
    Zhang ZL; Jiang QC; Wang SR
    Breast Cancer; 2018 Mar; 25(2):233-242. PubMed ID: 29181822
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Krüppel-like factor 4 promotes high-mobility group box 1-induced chemotherapy resistance in osteosarcoma cells.
    Huang J; Liu K; Song D; Ding M; Wang J; Jin Q; Ni J
    Cancer Sci; 2016 Mar; 107(3):242-9. PubMed ID: 26676883
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Altered expression of resistance associated genes in hepatoblastoma xenografts incorporated into mice following treatment with adriamycin or cisplatin.
    Bader P; Fuchs J; Wenderoth M; von Schweinitz D; Niethammer D; Beck JF
    Anticancer Res; 1998; 18(4C):3127-32. PubMed ID: 9713521
    [TBL] [Abstract][Full Text] [Related]  

  • 55. S9788 modulation of P-glycoprotein- and Multidrug-related protein-mediated multidrug resistance by Servier 9788 in doxorubicin-resistant MCF7 cells.
    Bichat F; Solis-Recendez G; Poullain MG; Poupon MF; Khayat D; Bastian G
    Biochem Pharmacol; 1998 Aug; 56(4):497-502. PubMed ID: 9763226
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased expression of multidrug resistance-associated proteins in bladder cancer during clinical course and drug resistance to doxorubicin.
    Tada Y; Wada M; Migita T; Nagayama J; Hinoshita E; Mochida Y; Maehara Y; Tsuneyoshi M; Kuwano M; Naito S
    Int J Cancer; 2002 Apr; 98(4):630-5. PubMed ID: 11920626
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential stabilization of topoisomerase-II-DNA cleavable complexes by doxorubicin and etoposide in doxorubicin-resistant rat glioblastoma cells.
    Montaudon D; Pourquier P; Denois F; de Tinguy-Moreaud E; Lagarde P; Robert J
    Eur J Biochem; 1997 Apr; 245(2):307-15. PubMed ID: 9151958
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interferon-alpha enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin by p53-dependent apoptosis.
    Yuan XW; Zhu XF; Huang XF; Sheng PY; He AS; Yang ZB; Deng R; Feng GK; Liao WM
    Acta Pharmacol Sin; 2007 Nov; 28(11):1835-41. PubMed ID: 17959036
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of β-elemene on the kinetics of intracellular transport of d-luciferin potassium salt (ABC substrate) in doxorubicin-resistant breast cancer cells and the associated molecular mechanism.
    Tang CY; Zhu LX; Yu JD; Chen Z; Gu MC; Mu CF; Liu Q; Xiong Y
    Eur J Pharm Sci; 2018 Jul; 120():20-29. PubMed ID: 29704644
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells.
    Liu F; Liu S; He S; Xie Z; Zu X; Jiang Y
    Oncol Rep; 2010 May; 23(5):1469-75. PubMed ID: 20372866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.